Featured Research

from universities, journals, and other organizations

Ovarian Cancer Subtypes Are Different Diseases: Implications For Biomarker Studies

Date:
December 14, 2008
Source:
Public Library of Science
Summary:
In a new analysis of tissue biomarkers expressed in ovarian cancer samples, published in PLoS Medicine, David Huntsman and his colleagues from Vancouver General Hospital suggest that substantial differences exist between ovarian cancer subtypes which should be reflected in patient management.

In a new analysis of tissue biomarkers expressed in ovarian cancer samples David Huntsman and his colleagues from Vancouver General Hospital suggest that substantial differences exist between ovarian cancer subtypes which should be reflected in patient management.

Although ovarian cancer is not the most common gynecologic cancer in women, the disease contributes a substantial burden of mortality in part because symptoms are nonspecific and the disease presents late in its course.

As part of their research, Huntsman and coworkers measured expression levels of 21 proteins in 500 ovarian cancer samples which had been collected by an ovarian cancer registry serving British Columbia, Canada; they then correlated expression of these biomarkers with patient survival data following standardized treatment. Their analyses studied associations between biomarker expression and survival for all cancers grouped together, as well as studying the five major ovarian cancer subtypes separately (high-grade serous, low-grade serous, clear cell, endometrioid, and mucinous carcinomas).

Although biomarker expression was stable across disease stages within a given subtype, the associations between specific biomarkers and disease outcome differed substantially between subtypes. As a result, the researchers propose that "our study offers persuasive evidence supporting the view that ovarian carcinoma subtypes are different diseases."


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. K๖bel et al. Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies. PLoS Medicine, 2008; 5 (12): e232 DOI: 10.1371/journal.pmed.0050232

Cite This Page:

Public Library of Science. "Ovarian Cancer Subtypes Are Different Diseases: Implications For Biomarker Studies." ScienceDaily. ScienceDaily, 14 December 2008. <www.sciencedaily.com/releases/2008/12/081201233445.htm>.
Public Library of Science. (2008, December 14). Ovarian Cancer Subtypes Are Different Diseases: Implications For Biomarker Studies. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/12/081201233445.htm
Public Library of Science. "Ovarian Cancer Subtypes Are Different Diseases: Implications For Biomarker Studies." ScienceDaily. www.sciencedaily.com/releases/2008/12/081201233445.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins